Dekker H - Search Results

1

Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.

Gotink KJ, Broxterman HJ, Labots M, de Haas RR, Dekker H, Honeywell RJ, Rudek MA, Beerepoot LV, Musters RJ, Jansen G, Griffioen AW, Assaraf YG, Pili R, Peters GJ, Verheul HM. Gotink KJ, et al. Among authors: dekker h. Clin Cancer Res. 2011 Dec 1;17(23):7337-46. doi: 10.1158/1078-0432.CCR-11-1667. Epub 2011 Oct 6. Clin Cancer Res. 2011. PMID: 21980135 Free PMC article.

2

Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.

Versantvoort CH, Broxterman HJ, Feller N, Dekker H, Kuiper CM, Lankelma J. Versantvoort CH, et al. Among authors: dekker h. Int J Cancer. 1992 Apr 1;50(6):906-11. doi: 10.1002/ijc.2910500615. Int J Cancer. 1992. PMID: 1348241

3

P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.

Spoelstra EC, Dekker H, Schuurhuis GJ, Broxterman HJ, Lankelma J. Spoelstra EC, et al. Among authors: dekker h. Biochem Pharmacol. 1991 Feb 1;41(3):349-59. doi: 10.1016/0006-2952(91)90531-9. Biochem Pharmacol. 1991. PMID: 1671638

4

Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.

Lankelma J, Spoelstra EC, Dekker H, Broxterman HJ. Lankelma J, et al. Among authors: dekker h. Biochim Biophys Acta. 1990 Dec 10;1055(3):217-22. doi: 10.1016/0167-4889(90)90035-c. Biochim Biophys Acta. 1990. PMID: 1979920

5

Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.

Spoelstra EC, Pinedo HM, Dekker H, Peters GJ, Lankelma J. Spoelstra EC, et al. Among authors: dekker h. Cancer Chemother Pharmacol. 1991;27(4):320-5. doi: 10.1007/BF00685119. Cancer Chemother Pharmacol. 1991. PMID: 1998989

6

Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.

Mülder HS, Lankelma J, Dekker H, Broxterman HJ, Pinedo HM. Mülder HS, et al. Among authors: dekker h. Int J Cancer. 1994 Oct 15;59(2):275-81. doi: 10.1002/ijc.2910590221. Int J Cancer. 1994. PMID: 7927929

7

Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G. van Kalken CK, et al. Among authors: dekker h. Br J Cancer. 1993 Feb;67(2):284-9. doi: 10.1038/bjc.1993.54. Br J Cancer. 1993. PMID: 8094292 Free PMC article.

8

Doxorubicin gradients in human breast cancer.

Lankelma J, Dekker H, Luque FR, Luykx S, Hoekman K, van der Valk P, van Diest PJ, Pinedo HM. Lankelma J, et al. Among authors: dekker h. Clin Cancer Res. 1999 Jul;5(7):1703-7. Clin Cancer Res. 1999. PMID: 10430072 Clinical Trial.

9

Analysis of multiple gene expression array experiments after repetitive hybridizations on nylon membranes.

Hornberg JJ, de Haas RR, Dekker H, Lankelma J. Hornberg JJ, et al. Among authors: dekker h. Biotechniques. 2002 Jul;33(1):108, 110, 112-3, passim. doi: 10.2144/02331rr02. Biotechniques. 2002. PMID: 12139235 Free article.

10

Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer.

Middelburg R, de Haas RR, Dekker H, Kerkhoven RM, Pohlmann PR, Fuentes-Alburo A, Mohar A, Pinedo HM, Lankelma J. Middelburg R, et al. Among authors: dekker h. Clin Cancer Res. 2005 Mar 1;11(5):1863-9. doi: 10.1158/1078-0432.CCR-04-1372. Clin Cancer Res. 2005. PMID: 15756011 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page